Yamada, Ken https://orcid.org/0000-0002-5714-8298
Hariharan, Vignesh N. https://orcid.org/0000-0001-9624-1244
Caiazzi, Jillian https://orcid.org/0000-0002-7077-2116
Miller, Rachael https://orcid.org/0000-0002-4594-0640
Ferguson, Chantal M. https://orcid.org/0000-0002-9442-1249
Sapp, Ellen
Fakih, Hassan H. https://orcid.org/0000-0002-7598-0993
Tang, Qi https://orcid.org/0000-0002-8913-0519
Yamada, Nozomi
Furgal, Raymond C. https://orcid.org/0000-0002-4757-7339
Paquette, Joseph D. https://orcid.org/0009-0004-8536-8951
Biscans, Annabelle
Bramato, Brianna M.
McHugh, Nicholas https://orcid.org/0000-0003-2004-0811
Summers, Ashley https://orcid.org/0000-0002-5425-0457
Lochmann, Clemens https://orcid.org/0009-0005-3869-8242
Godinho, Bruno M. D. C. https://orcid.org/0000-0001-6192-3333
Hildebrand, Samuel
Jackson, Samuel O. https://orcid.org/0000-0001-8194-9100
Echeverria, Dimas
Hassler, Matthew R. https://orcid.org/0000-0001-7897-6503
Alterman, Julia F. https://orcid.org/0000-0002-6195-0857
DiFiglia, Marian
Aronin, Neil
Khvorova, Anastasia https://orcid.org/0000-0001-6928-8071
Funding for this research was provided by:
CHDI Foundation (RecID A-5038)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 NS104022)
MIRA: NIH grant for Maximizing Investigator's Research Award S10: NIH grant of Instrumentation Program
Article History
Received: 26 May 2023
Accepted: 25 June 2024
First Online: 1 August 2024
Competing interests
: K.Y., V.N.H. and A.K. have filed patent applications for exNA platforms. A.K. discloses ownership of stocks in RXi Pharmaceuticals and Advirna, and is a founder of Atalanta Therapeutics and Comanche Biopharma. V.N.H. is an employee of Comanche Biopharma and owns stock options. The remaining authors declare no competing interests.